Vincasar PFS

Known as: PFS, Vincasar 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to… (More)
Is this relevant?
2014
2014
BACKGROUND Pazopanib recently received approval for the treatment of certain soft tissue sarcoma (STS) subtypes. We conducted a… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2012
2012
OBJECTIVE A phase II trial was performed to evaluate the efficacy and safety of the tyrosine kinase inhibitor of epidermal growth… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVE Patients with persistent/recurrent epithelial ovarian cancer/primary peritoneal cancer (EOC/PPC) have limited treatment… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2011
2011
BACKGROUND The authors investigated the putative surrogate endpoints of best response, complete response (CR), confirmed response… (More)
  • table 3
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2010
2010
BACKGROUND AND PURPOSE PFS occurs in approximately 25% of pediatric patients receiving surgery for midline posterior fossa tumors… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Recurrent malignant gliomas have a very poor prognosis. This trial aimed to evaluate the benefits of reirradiation in case of… (More)
  • figure 2
  • figure 3
  • figure 1
  • figure 4
  • figure 5
Is this relevant?
2009
2009
How much precipitation is contributed by warm rain systems over the tropics? What is the typical size, intensity, and echo top of… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2008
2008
PURPOSE Sarcomas are among the most proangiogenic malignancies in preclinical models. Phase I study results for ABT-510, which… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2003
2003
Protofibrils (PFs) are recently described intermediate assemblies formed during the fibrillogenesis of amyloidogenic proteins and… (More)
Is this relevant?